MARKET

PSTI

PSTI

Pluristem
NASDAQ

Real-time Quotes | Nasdaq Last Sale

4.080
+0.080
+2.00%
Closed 16:00 01/17 EST
OPEN
4.030
PREV CLOSE
4.000
HIGH
4.150
LOW
3.980
VOLUME
171.45K
TURNOVER
--
52 WEEK HIGH
11.90
52 WEEK LOW
3.110
MARKET CAP
64.10M
P/E (TTM)
-1.5680
1D
5D
1M
3M
1Y
5Y

Buy or sell shares of PSTI and other stocks commission-free!

Open a Webull account and fund it to get a free stock

Analyst Rating

Based on 4 analysts

Buy

Disclaimer: The analysis information is for reference only and does not constitute an investment recommendation.

EPS

PSTI News

  • Does The Pluristem Therapeutics Inc. (NASDAQ:PSTI) Share Price Fall With The Market?
  • Simply Wall St..01/09 16:53
  • Pluristem Completes 75% Enrollment in its Pivotal Phase III CLI Clinical Study
  • GlobeNewswire.12/17/2019 12:00
  • Benzinga's Top Upgrades, Downgrades For December 16, 2019
  • Benzinga.12/16/2019 15:10
  • Goldman likes Amgen and UnitedHealth Group in premarket analyst action
  • Seeking Alpha - Article.12/16/2019 13:14

More

Industry

Biotechnology & Medical Research
-0.16%
Pharmaceuticals & Medical Research
+0.06%

Hot Stocks

Name
Price
%Change

About PSTI

Pluristem Therapeutics Inc. is a developer of placenta-based cell therapy product candidates for the treatment of multiple ischemic, inflammatory and hematologic conditions. The Company's lead indications are critical limb ischemia (CLI), recovery after surgery for femoral neck fracture and acute radiation syndrome. Its operations are focused on the research, development, clinical trials and manufacturing of cell therapeutics and related technologies. The Company's products include PLX-PAD and PLX R18. The Company's PLX cells are adherent stromal cells (ASCs) that are expanded using a three dimensional (3D) process. The system utilizes a synthetic scaffold to create an artificial 3D environment where placental-derived stromal cells can grow. The Company's PLX products are administered using a standard needle and syringe. The Company's PLX products are in clinical-stage development for multiple indications, such as cardiovascular, orthopedic, pulmonary and women's health diseases.
More

Webull offers Pluristem Therapeutics Inc. (PSTI) stock price, real-time market quotes, financial reports, professional analyst ratings, in-depth charts, corporate actions, stock news, and many more online research tools to help you make informed decisions.